Check out all the latest news from SENS Research Foundation in our second June newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!
Control ALT, Delete Cancer
SENS Research Foundation is pleased to announce our new crowdfunding campaign in collaboration with Lifespan.io, raising funds to test drugs against some of the most deadly cancers. We've just issued a press release with much more detail on the campaign.
SENS Research Foundation's work is the subject of the latest volume in Zero Books' series Advancing Conversations. Available now, the book documents a series of interviews with Dr. de Grey covering recent progress and our responses to critics.
Shopping for Father's Day, graduation or another celebration? When you use our Amazon Smile link, Amazon automatically donates part of your payment to SRF - and it won't cost you an extra cent!
Summer Scholar Selfies
See the SRF Summer Scholars Program through the eyes of the Summer Scholars themselves. Shot entirely by the students, this video not only highlights the 2015 host research institutions and a few of the labs but also the camaraderie of the experience.
Ending Aging Audiobook
Our general introduction to SENS research, Ending Aging, is now available in audiobook format. All profits will go to SENS Research Foundation. If Ending Aging is your first purchase as a new Audible member, we also get a $50 "bounty" - so please consider signing up!
Regeneration vs. Aging
A new article in Genetic Engineering & Biotechnology News explores how applying regenerative medicine to the accumulated damage of aging is becoming an increasingly mainstream idea, crediting SRF CSO Aubrey de Grey as a pioneer in the field.
Top-Rated for 2016?
In 2015 SENS Research Foundation was recognised as a Top-Rated Nonprofit by GreatNonprofits.org - the only people's choice award in the nonprofit sector. Please help us earn the award again in 2016 by writing a short review of why our work matters to you!
Open Access, Faster Cures
In a new case study, a team led by Rejuvenation Biotechnology 2015 keynote speaker Chas Bountra and SRF-funded researcher David Brindley demonstrate the multiple benefits of an open access model in early-stage drug development.
Investing in Ichor
Ichor Therapeutics, a New York biotechnology company founded by original SRF Education leader Kelsey Moody, has announced $1.35m in new funding. The investments will be used to expand pre-clinical facilities and support Ichor's ongoing work on age-related disease.
Loading Up With Lipofuscin
The SENS Research Foundation-funded team at Rice University has just published an open access paper detailing a fast, simple method for generating the age-related pigment lipofuscin in cells and screening the effectiveness of drugs for its removal.
Lifespans Are (Not) Long Enough
Our CSO Dr. Aubrey de Grey, and Buck Institute for Research on Aging CEO Brian Kennedy, successfully opposed the motion that "Lifespans Are Long Enough" in debate at the Kaufman Center on February 3rd. A full video of the debate is now available.
The Curse of MiDAS
An SRF-supported team at the Buck Institute has identified a distinct form of mitochondrially-driven cellular senescence. The phenomenon may be a factor in any disease with a mitochondrial component, including many neurodegenerative conditions.
SRF Research Published in Science
An SRF-funded study by Yale University Professor David Spiegel has been published in world-leading journal Science. The discoveries announced will accelerate future research in the fields of diabetes and age-related tissue cross-linking.